Coagulation Factor VIII  (Recombinant)                                                                                                               

Factor VIII (FVIII) is a protein in blood plasma that is essential to the blood clotting process. A genetic deficiency of FVIII is treated by replacing the missing factor. Lyophilized concentrations of each brand of factor are either manufactured through recombinant technology or derived from human plasma. Replacement therapy is administered intravenously for the prevention and control of bleeding episodes in patients with FVIII deficiency, also known as Hemophilia A. Factor products are supplied in vial sizes of varying iu (international units) which may change with each new lot of product manufactured.